Day 1 - Oct 8 14:40-16:00 |
Session 7. TARE for HCC: Different regions, different roles Grand Ballroom (Hanra) 1 |
---|
14:40-15:00 | The role of TARE in Taiwan PiYi Chang (Taichung Veterans General Hospital, Taiwan) |
---|---|
15:00-15:20 | The role of TARE in Singapore Lawrence Quek (Tan Tock Seng Hospital, Singapore) |
15:20-15:40 | The role of TARE in Korea Jin Woo Choi (Seoul National University, Korea) |
15:40-16:00 | The role of TARE in the State Edward Wolfgang Lee (UCLA Medical center, USA) |
Day 1 - Oct 8 10:50-12:10 |
Live Demonstration 2 (VOD) Grand Ballroom (Hanra) 2 |
---|
16:00-16:40 | VOD 1(Kiang Hiong Tay, (Singapore General Hospital, Singapore) |
---|---|
16:40-17:10 | VOD 2(Hyun Pyo Hong, Sungkyunkwan University, Korea) |
Day 1 - Oct 8 16:00-17:20 |
Session 8. Combination therapies for HCC: When and why Grand Ballroom (Hanra) 1 |
---|
16:00-16:20 | TACE combined with ablation Jiaywei Tsauo (Guangdong Provincial People’s Hospital, China) |
---|---|
16:20-16:40 | Combination of locoregional therapies and surgery Dongho Hyun (Sunkyunkwan University, Korea) |
16:40-17:00 | Combination of transarterial therapies and systemic therapies Yozo Sato (Aichi Cancer Center Hospital, Japan) |
17:00-17:20 | Value driven care in locoregional treatment of hepatocellular carcinoma Kiang Hiong Tay (Singapore General Hospital, Singapore) |